Member Info for stephen11

- Large pre-orders were announced alongside the CE marking
- An RNS appeared regarding hearing loss
- We had peace on earth
- Father Christmas arrives
- And BigAl gets to fire the rocket up for 10 trading days in a row

Stephen11

I’ve been up, down, and shaken around by this share. I averaged up, then averaged down, and have never sold a penny.

In hindsight I should have topsliced at £1.50 last February.

Hopefully better days head.

Fair play mate - hope you get some money back, and a bit more.

The ducks are aligned, me thinks.

Well, that was very therapeutic. I have just filtered around 20 absolute tw?ts - i don't know where they all came from? Clogging up the board with dribble.

Even Maestro1 was never that bad - at least you could have a bit of debate with him.

Anyway, onwards and upwards for tomorrow.

Are you back in Northeast14. If so, welcome back!

I hope to see a round £1.00 today.

I’m thinking about 75p at close today, but will be happy if this figure is conservative.

GLA.

BigAl….I hope you’ve got plenty of high-octane fuel for today my friend!

Fair shout Dave77,

I’m calling it £1.25 in 10 days, if we get CE marking and really good news in respect of the hearing loss product.

Genuine question?

Anyone brave enough to make an SP prediction?

Stephen11.

Out of the fire i shall rise again

Stop clogging up the board with your constant rambling.

You are talking a load of ****.

Anyway, enough said.

You are now a green box.

I posted this last week, but just as perspective.

What I do know is that this share can move like a rocket on positive news. I had a little look at my share dealing diary for the start of 2021!

- Jan 21st 2021: SP = 42p
- Feb 12th 2021: SP = 148p

Might this what we have to look forward to?

And what if hearing loss news drops?

OK....we've waited long enough....fire up the rocket BigAl and congrats on your buy in Dave11.

Reply to PennyStock,

- If you are berating me for being happy because of Fridays SP - I'm guilty as charged
- If you are berating me for being happy at the prospect of myself and others on this board getting out of a significant paper loss - I'm guilty as charged
- If you feel the need to dampen my enthusiasm on what is the best Genedrive RNS in around 10 months - go ahead

Enough said.

Sincere best wishes to all the long-suffering long-term holders out there!

Stephen11.

I hope she’s well fuelled up BigAl - I’m thinking you will need to send that rocket up around 10am!? It’s been too long!

Things could get spicy today?

GLA

Stephen11

Good to hear from you BigAl,

I’m the same, haven’t sold one share and have managed to average down considerably. In hindsight, I should have taken some profit at £1.50 and left some in on a free run.

I’ve been moving into a few lithium and gold stocks (for long-term growth), so hopefully that will turn out well.

I hope you’ve got high grade fuel in that thing - we might need it next week.

Lol.

Let’s hope so Dave, maybe the rising tide in diagnostics will lift all boats, including GDR. Can’t see NCYT going back to the glory days of +1150, but was also thinking of taking a punt next week. 500p might be plausible.

That’s one thing I’ve really missed over lockdown - cruising. I had a P & O 2 week Med cruise cancelled for July 2020, rebooked it for 2021 which was cancelled again. Fingers crossed I get July 2022. Good luck with your cruise.

Do you think we have a chance Dave77. I think the FDA ship has sailed, though would love to be proved wrong!

I am encouraged by the hearing loss/POC, as long as Dudd doesn’t fluck it up!?

What I do know is that this share can move like a rocket on positive news. I had a little look at my share dealing diary for the start of 2021!

- Jan 21st 2021: SP = 42p
- Feb 12th 2021: SP = 148p

If the ducks line up (POC and Hearing Loss) we might be in with a chance!

I’m hoping for an RNS early next week!

You guys still got that GDR rocket?

By the way, how is my friend BigAl - bit cold now for the fishing, I’m sure?

Lol

GLA.

Direct quote from the Stock Watch section below, by Archie Mitchell.

“Manchester-based molecular diagnostics firm Genedrive was a big winner on the junior AIM market yesterday, soaring 32.6pc, or 5.7p, to 23.2p.

It said earlier this month it was too late launching its COVID test and was ‘disappointed with falling short on expectation’. But if the new Omicron variant takes grip, COVID tests could once again be in huge demand. Traders also speculated it could become a take-over target as shares are still below this year’s high of 149p hit in March.”

Something must be going on in the background.

Happy days - at last!

Kodal, Prem, and lots of other stocks with exposure in Africa are all down today, partly due to the emerging news of the new SA variant.

If anything it is a good time to buy.

Keep thinking about increasing demand for lithium and the increasing price per tonne. These are the fundamentals that will move the share price up in the next 2 years.

Stephen11.

Thanks Stars,

You raise some very valid points. This new variant could put the cat amongst the pigeons and give this share another chance.

I’m away to the Black Friday sales - will check in again later.

Stephen11.